Analyst consensus rating
AtriCure Analyst Rating: Buy
Direct answer
AtriCure's consensus rating is Buy.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $64.89.
Forecast evidence checked November 14, 2026.
Get free AtriCure email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $56.84
- Average price target
- $64.89
- High price target
- $70.00
- Low price target
- $50.00
- Low target gap
- -12%
- Target upside
- +14.2%
- High target gap
- +23.2%
- Target range width
- 35.2%
- Consensus rating
- Buy
- Analysts
- 9
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for AtriCure?
AtriCure has a verified Buy consensus. The same dataset has an average price target of $64.89.
How far are AtriCure's low and high targets from the recorded price?
The low target implies -12%, while the high target implies +23.2%.
How many analysts are included in AtriCure's consensus?
The verified consensus includes 9 analysts.
How is AtriCure's target upside or downside calculated?
The average target of $64.89 is divided by the recorded price of $56.84, then one is subtracted to produce +14.2%. This does not guarantee a future return.
When was AtriCure's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.